Back to Search
Start Over
Classification of Companion Diagnostics: A New Framework for Biomarker-Driven Patient Selection
- Source :
- Therapeutic innovation & regulatory science, Ahead of, Therapeutic innovation & regulatory science: official journal of DIA 56(2), 244-254 (2022). doi:10.1007/s43441-021-00352-2
- Publication Year :
- 2021
-
Abstract
- Therapeutic innovation & regulatory science: official journal of DIA 56(2), 244-254 (2022). doi:10.1007/s43441-021-00352-2<br />Published by Springer Nature, [New York]
- Subjects :
- Drug
medicine.medical_specialty
business.industry
media_common.quotation_subject
Patient Selection
Public Health, Environmental and Occupational Health
Pharmacy
Companion diagnostic
Classification
Patient selection
Predictive
Prognostic
Biomarker
Marketing authorization
Drug development
medicine
Clinical endpoint
Biomarker (medicine)
Humans
Pharmacology (medical)
Personalized medicine
Intensive care medicine
business
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Drug Approval
Biomarkers
media_common
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Therapeutic innovation & regulatory science, Ahead of, Therapeutic innovation & regulatory science: official journal of DIA 56(2), 244-254 (2022). doi:10.1007/s43441-021-00352-2
- Accession number :
- edsair.doi.dedup.....53e88cabbf2443ad3ecd46713cfd2b9f
- Full Text :
- https://doi.org/10.1007/s43441-021-00352-2